Molecular Mechanisms of Palmitic Acid Augmentation in COVID-19 Pathologies

Area of Science:

• Molecular biology
• Immunology
• Virology

Background:

• Obesity is linked to severe COVID-19 outcomes, but underlying molecular mechanisms remain unclear.
• Elevated free fatty acids (FFAs) are characteristic of obesity and may influence disease severity.
• Understanding FFA impact on COVID-19 pathogenesis is crucial for therapeutic strategies.

Purpose of the Study:

• To investigate how excess free fatty acids (FFAs), specifically palmitic acid (PA), affect COVID-19 progression.
• To identify molecular pathways and mediators influenced by PA in the context of coronavirus infection.
• To explore the potential protective role of n-3 fatty acids against PA-induced exacerbation of COVID-19.

Main Methods:

• Utilized QIAGEN Knowledge Base to retrieve data on palmitic acid (PA) and COVID-19 related molecules.
• Employed Ingenuity Pathway Analysis (IPA) to analyze datasets and identify affected biological pathways.
• Focused on key inflammatory mediators, cytokines, chemokines, transcription factors, and apoptotic factors.

Main Results:

• Palmitic acid (PA) significantly impacts the coronavirus pathogenesis pathway, involving mediators like PTGS2, IL1β, IL6, CCL2, CCL5, NFκB, EEF1A1, and BAX.
• n-3 fatty acids demonstrated potential to attenuate PA-driven activation of this pathway by inhibiting mediators such as IL1β, CCL2, PTGS2, and BAX.
• PA may also influence the expression of ACE2, the primary receptor for SARS-CoV-2.

Conclusions:

• Excess palmitic acid (PA) exacerbates COVID-19 pathogenesis through activation of key inflammatory and apoptotic pathways.
• n-3 fatty acids may counteract PA's detrimental effects, suggesting a potential therapeutic role.
• Further research into FFA modulation of ACE2 and inflammatory pathways is warranted for COVID-19 treatment.